The MCDA method developed in WP4 will be used to evaluate the 16 promising ICC for multi-morbidity projects selected in WP1, and extensively described in WP2. Overall the objectives of this work package are:
In this work package study protocols, applying the study designs selected in WP4, will be written for each of the ICC projects that will be evaluated. These are the projects that were identified in WP1 and described extensively in WP2. Data will be collected on the performance indicators and MCDA’s will be conducted. Hereafter, a user-friendly performance monitoring tool based on the MCDA will be developed in Excel and made freely accessible online.
Other partners involved: